Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04071951 · ClinicalTrials.gov registry record · NA
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
A NA study of Polypharmacy and Nonadherence, Patient, sponsored by Cedars-Sinai Medical Center.
- Active
- Registry status
- NA
- Development phase
- 6,478
- Enrollment target
- 2
- Study locations
NCT04071951 is a NA study of Polypharmacy and Nonadherence, Patient that is active but no longer recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 6,478 participants, above the 791-participant average among 8 other Polypharmacy trials with a reported enrollment target (719% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04071951, a NA study of Polypharmacy and Nonadherence, Patient, is active but no longer recruiting, sponsored by Cedars-Sinai Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6,478 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized trial testing a peri- and post-discharge pharmacist-led medication management intervention on post-discharge utilization, including both readmissions and emergency department visits within 30 days of discharge. The intervention incorporates evidence addressing three main areas: medication reconciliation, medication adherence, and polypharmacy. This study uses a pragmatic trial randomized at the patient level and conducted in two large hospitals to achieve the following aims, each of which has been designed using the RE-AIM framework: Aim 1: To test the effect of PHARM-DC on post-discharge utilization among patients most at risk for post-discharge ADEs: recently discharged older adults taking \>10 medications or \>3 high-risk medications using a prospective, randomized, pragmatic multi-site study. Aim 2: To study barriers and facilitators of implementing PHARM-DC using a qualitative study. Aim 3: To analyze the costs of PHARM-DC, including the incremental cost per readmission averted and the net incremental cost from the health system perspective using a time-and-motion study and a cost-effectiveness analysis.
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist-led Hospital Discharge Care Intervention
Study Locations (2)
California
- Cedars-Sinai Medical Center - Los Angeles
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,478 participants |
| Start Date | 2019-12-23 |
| Est. Completion | 2026-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04071951
The ClinicalTrials.gov registry entry for NCT04071951 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6,478 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 791-participant average among 8 other Polypharmacy trials with a reported enrollment target (719% higher). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist-led Hospital Discharge Care Intervention is the first listed.
NCT04071951 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04071951 about?
NCT04071951 is a clinical study titled "Pharmacist Intervention to Reduce Post-Hospitalization Utilization". This is a randomized trial testing a peri- and post-discharge pharmacist-led medication management intervention on post-discharge utilization, including both readmissions and emergency department visits within 30 days of discharge. The intervention incorporates evidence addressing three main areas: ...
What is the current status of trial NCT04071951?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6,478 participants. The study started on 2019-12-23. Estimated completion is 2026-01-15.
What conditions does trial NCT04071951 study?
This clinical trial studies the following conditions: Polypharmacy, Nonadherence, Patient, Readmission.
What interventions are being tested in trial NCT04071951?
The interventions under investigation include: Pharmacist-led Hospital Discharge Care Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04071951?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04071951 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Medication Management in World Trade Center Responders
RECRUITING · NA
-
Effectiveness of PGx Testing
ACTIVE NOT RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
COMPLETED · NA
-
Tailored Medication Management Intervention
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.